256 related articles for article (PubMed ID: 16043992)
1. Stepwise regulation of TH1 responses in autoimmunity: IL-12-related cytokines and their receptors.
Becker C; Wirtz S; Neurath MF
Inflamm Bowel Dis; 2005 Aug; 11(8):755-64. PubMed ID: 16043992
[TBL] [Abstract][Full Text] [Related]
2. The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases.
Hölscher C
Med Microbiol Immunol; 2004 Feb; 193(1):1-17. PubMed ID: 12836019
[TBL] [Abstract][Full Text] [Related]
3. IL-12 and IL-23: master regulators of innate and adaptive immunity.
Langrish CL; McKenzie BS; Wilson NJ; de Waal Malefyt R; Kastelein RA; Cua DJ
Immunol Rev; 2004 Dec; 202():96-105. PubMed ID: 15546388
[TBL] [Abstract][Full Text] [Related]
4. Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunity.
Puccetti P; Belladonna ML; Grohmann U
Crit Rev Immunol; 2002; 22(5-6):373-90. PubMed ID: 12803317
[TBL] [Abstract][Full Text] [Related]
5. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S
Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464
[TBL] [Abstract][Full Text] [Related]
6. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4.
Watford WT; Hissong BD; Bream JH; Kanno Y; Muul L; O'Shea JJ
Immunol Rev; 2004 Dec; 202():139-56. PubMed ID: 15546391
[TBL] [Abstract][Full Text] [Related]
7. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders.
Gee K; Guzzo C; Che Mat NF; Ma W; Kumar A
Inflamm Allergy Drug Targets; 2009 Mar; 8(1):40-52. PubMed ID: 19275692
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-12 and the regulation of innate resistance and adaptive immunity.
Trinchieri G
Nat Rev Immunol; 2003 Feb; 3(2):133-46. PubMed ID: 12563297
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of interleukin-23 in experimental autoimmune encephalomyelitis.
Touil T; Fitzgerald D; Zhang GX; Rostami AM; Gran B
Drug News Perspect; 2006 Mar; 19(2):77-83. PubMed ID: 16628262
[TBL] [Abstract][Full Text] [Related]
10. A unique role for IL-23 in promoting cellular immunity.
Lankford CS; Frucht DM
J Leukoc Biol; 2003 Jan; 73(1):49-56. PubMed ID: 12525561
[TBL] [Abstract][Full Text] [Related]
11. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells.
Hoeve MA; Savage ND; de Boer T; Langenberg DM; de Waal Malefyt R; Ottenhoff TH; Verreck FA
Eur J Immunol; 2006 Mar; 36(3):661-70. PubMed ID: 16482511
[TBL] [Abstract][Full Text] [Related]
12. New mediators of immunity and inflammation in inflammatory bowel disease.
Monteleone G; Fina D; Caruso R; Pallone F
Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 27 signaling pathways in regulation of immune and autoimmune responses.
Yoshida H; Miyazaki Y
Int J Biochem Cell Biol; 2008; 40(11):2379-83. PubMed ID: 18588993
[TBL] [Abstract][Full Text] [Related]
14. Novel IL-12 family members shed light on the orchestration of Th1 responses.
Brombacher F; Kastelein RA; Alber G
Trends Immunol; 2003 Apr; 24(4):207-12. PubMed ID: 12697453
[TBL] [Abstract][Full Text] [Related]
15. IL-23 and IL-27: new members of the growing family of IL-12-related cytokines with important implications for therapeutics.
Cordoba-Rodriguez R; Frucht DM
Expert Opin Biol Ther; 2003 Aug; 3(5):715-23. PubMed ID: 12880372
[TBL] [Abstract][Full Text] [Related]
16. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.
Hunter CA
Nat Rev Immunol; 2005 Jul; 5(7):521-31. PubMed ID: 15999093
[TBL] [Abstract][Full Text] [Related]
17. An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis.
Toichi E; Torres G; McCormick TS; Chang T; Mascelli MA; Kauffman CL; Aria N; Gottlieb AB; Everitt DE; Frederick B; Pendley CE; Cooper KD
J Immunol; 2006 Oct; 177(7):4917-26. PubMed ID: 16982934
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.
Cua DJ; Sherlock J; Chen Y; Murphy CA; Joyce B; Seymour B; Lucian L; To W; Kwan S; Churakova T; Zurawski S; Wiekowski M; Lira SA; Gorman D; Kastelein RA; Sedgwick JD
Nature; 2003 Feb; 421(6924):744-8. PubMed ID: 12610626
[TBL] [Abstract][Full Text] [Related]
19. IL-12 in autoimmunity.
Caspi RR
Clin Immunol Immunopathol; 1998 Jul; 88(1):4-13. PubMed ID: 9683544
[No Abstract] [Full Text] [Related]
20. IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis.
Becher B; Durell BG; Noelle RJ
J Clin Invest; 2003 Oct; 112(8):1186-91. PubMed ID: 14561703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
